Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Frontiers in Psychiatry|January 20, 2023
Mapping the implementation and challenges of clinical services for psychosis prevention in EnglandAndrés Estradé, Tom John Spencer, Andrea De Micheli, et al.BMJ Open Respiratory Research|June 19, 2023
Rehabilitation outcomes for people with lung cancer (UNITE): protocol for the development of a core outcome setLara Edbrooke, Catherine L Granger, Jill J Francis, et al.Translational Lung Cancer Research|July 23, 2021
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitorsKanishka Rangamuwa, Tracy Leong, Clare Weeden, et al.British Journal of Cancer|December 26, 2022
Predicting response to immune checkpoint blockade in NSCLC with tumour-only RNA-seqJohn F Markham, Andrew P Fellowes, Thomas Green, et al.Lung Cancer (Amsterdam, Netherlands)|March 21, 2024
The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancerNeil D Wallace, Marliese Alexander, Jing Xie, et al.Clinical Lung Cancer|August 12, 2020
Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLCEvangeline Samuel, Gabrielle Lie, Adithya Balasubramanian, et al.Lung Cancer (Amsterdam, Netherlands)|May 1, 2025
EGFR mutation testing across the osimertinib clinical programMarie Laure Murat-Onana, Suresh S Ramalingam, Pasi A Jänne, et al.Clinical Lung Cancer|March 20, 2025
Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort StudyNeil D Wallace, Jing Xie, Marliese Alexander, et al.Schizophrenia Research|September 21, 2020
Lower speech connectedness linked to incidence of psychosis in people at clinical high riskTom John Spencer, Bethany Thompson, Dominic Oliver, et al.Translational Lung Cancer Research|May 20, 2021
Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinibPei N Ding, Tara L Roberts, Wei Chua, et al.Pageof 3